Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 10,000 | 0 | 0 | 0 | 439 |
| Gross Profit | 10,000 | N/A | N/A | 0 | 439 |
| Operating Expenses | 45,251 | 45,118 | 34,897 | 29,022 | 36,281 |
| Operating Income | -35,251 | -45,118 | -34,897 | -29,022 | -35,842 |
| Other Income | 10,938 | 11,260 | 11,389 | 8,806 | 7,783 |
| Pre-tax Income | -24,313 | -33,858 | -23,508 | -20,216 | -28,059 |
| Net Income Continuous | -24,313 | -33,858 | -23,508 | -20,216 | -28,059 |
| Net Income | $-24,313 | $-33,858 | $-23,508 | $-20,216 | $-28,059 |
| EPS Basic Total Ops | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 |
| EPS Basic Continuous Ops | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 |
| EPS Diluted Total Ops | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 |
| EPS Diluted Continuous Ops | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 |
| EBITDA(a) | $-39,373 | $-49,783 | $-38,599 | $-31,437 | $-38,230 |